Search Results for compound
Searching compound for iso alnustone a returned 26073 results.
Displaying compounds 22826 - 22850 of 26073 in total
FDB013365
7558-80-7
sodium dihydrogen phosphate
Matched description: … It is used in foods as a dry acidulant, buffering agent, emulsifier, leavening agent, protein modifier …
FDB022548
46495-39-0
{[(1S,2R,3S,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphonic acid
Matched description: … D-Myo-inositol 4-phosphate is a substrate for Inositol monophosphatase, Inositol polyphosphate 1-phosphatase …
FDB005374
313-04-2
(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol
Matched description: … Desmosterolosis is a rare autosomal recessive inborn errors of cholesterol synthesis that is caused by ... desmosterol reductase which results in an accumulation of demosterol (DHCR24, EC 1.3.1.72), combines a ... The hedgehog proteins include Sonic hedgehog (SHH), which plays a major role in midline patterning and …
FDB005583
529-69-1
2-amino-1,4,7,8-tetrahydropteridine-4,7-dione
Matched description: … A significant decrease of isoxanthopterin has been determined in cancer patients. ... Isoxanthopterin is a pteridine normally present in plasma, urine, and other bodily fluids also vary from ... ' urinary concentrations seem to vary independently from each other and from normal values to yield a …
FDB021979
17974-66-2
(6R)-6-[(1S,2S,5R,7S,9R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2-methylheptanoic acid
Matched description: … 3a,7a-Dihydroxycoprostanic acid is a bile acid excreted in small amounts in the urine of healthy subjects ... (PMID 864325)
3a,7a-Dihydroxycoprostanic acid is the precursor to chenodeoxycholic acid
A bile acid. ... They exist as anions at physiological pH and, consequently, require a carrier for transport across the …
FDB022192
6418-78-6
3-(hexanoyloxy)-4-(trimethylazaniumyl)butanoate
Matched description: … causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its ... The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain ... Hexanoylcarnitine is a medium-chain acylcarnitine present in the urine of patients with medium-chain …
FDB028335
117997-17-8
2-[(4R)-4-[(2R,5R,7R,8R,9S,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid
Matched description: … Taurohyocholate is a bile acid. ... It is a product of the metabolism of Taurochenodeoxycholate which is catalyzed by the enzyme CYP3A4. ... They exist as anions at physiological pH and, consequently, require a carrier for transport across the …
FDB011840
593-45-3
octadecane
Matched description: … Thus, octadecane is a hydrocarbon lipid molecule. ... This could make octadecane a potential biomarker for the consumption of these foods. ... Octadecane, also known as CH3-[CH2]16-CH3 or oktadekan, is a straight-chain alkane carrying 18 carbon …
FDB021824
531-95-3
(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol
Matched description: … Equol is a metabolite of daidzein, a phytoestrogen common in the human diet and abundant in soy. ... The clinical effectiveness of soy isoflavones may be a function of the ability to biotransform soy isoflavones …
FDB022487
146-91-8
[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid
Matched description: … Guanosine diphosphate is a moderately basic compound (based on its pKa). ... This could make guanosine diphosphate a potential biomarker for the consumption of these foods. ... A purine ribonucleoside 5'-diphosphate resulting from the formal condensation of the hydroxy group at …
FDB022513
7418-61-3
trimethyl(2-oxoethyl)azanium
Matched description: … Betaine aldehyde is a substrate for Choline dehydrogenase (mitochondrial). ... This could make betaine aldehyde a potential biomarker for the consumption of these foods. ... These are organonitrogen compounds containing a quaternary ammonium substituted with four alkyl chains …
3-(octadec-11-en-1-yloxy)-4-(trimethylazaniumyl)butanoate
Matched description: … Vaccenyl carnitine is a long-chain acyl fatty acid derivative ester of carnitine. ... severe infantile hepatocardiomuscular form and (ii) a milder adult muscular form. ... an autosomal recessive disorder of fatty acid metabolism presenting as two clinical phenotypes: (i) a …
FDB023928
36816-10-1
(3R)-3-(octadeca-9,12-dienoyloxy)-4-(trimethylazaniumyl)butanoate
Matched description: … Linoleyl carnitine is a long-chain acyl fatty acid derivative ester of carnitine. ... severe infantile hepatocardiomuscular form and (ii) a milder adult muscular form. ... an autosomal recessive disorder of fatty acid metabolism presenting as two clinical phenotypes: (i) a …
[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-2-(octadecanoyloxy)propoxy]phosphoryl}oxy)propoxy]phosphonic acid
Matched description: … These lipids contain a common glycerophosphate skeleton linked to at least one fatty acyl chain and a ... The are synthesized by the addition of glycerol 3-phosphate to a CDP-diacylglycerol. …
[(2S)-3-({[(2R)-2,3-bis[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid
Matched description: … These lipids contain a common glycerophosphate skeleton linked to at least one fatty acyl chain and a ... The are synthesized by the addition of glycerol 3-phosphate to a CDP-diacylglycerol. …
N-[(2S,3R)-1-{[(2R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enimidic acid
Matched description: … Lactosylceramide (d18:1/24:1(15Z)) is a lactosylceramide or LacCer. ... It is found in small amounts only in most animal tissues, but it has a number of significant biological ... monosaccharides unit (galactose) as its nucleotide derivative to monoglucosylceramide, catalysed by a …
(2-{[(2R)-3-(icosa-5,8,11-trienoyloxy)-2-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-3-(icosa-8,11,14-trienoyloxy)-2-(octadeca-6,9,12,15-tetraenoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-2-(icosa-5,8,11,14,17-pentaenoyloxy)-3-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-2-(docosa-4,7,10,13,16-pentaenoyloxy)-3-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-2-(docosa-4,7,10,13,16,19-hexaenoyloxy)-3-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-2-(docosa-4,7,10,13,16-pentaenoyloxy)-3-(icosa-5,8,11,14-tetraenoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …
(2-{[(2R)-3-(icosa-5,8,11,14,17-pentaenoyloxy)-2-(octadeca-6,9,12-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
Matched description: … It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site ... PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)) is a phosphatidylcholine (PC or GPCho). ... A third route to PC synthesis involves the conversion of either PS or PE to PC. [HMDB] …